Most recently released targets
In the race to the next big breakthrough, you need to have the best tools available. We are constantly working to keep pace with the speed of your innovation to provide you with the products you need.
New assays/kits for life science are available in innovative assay platforms such as AlphaLISA™ SureFire® Ultra™, AlphaLISA, HTRF™, and pHSense™, within several different therapeutic areas and research fields.
In the race to the next big breakthrough, you need to have the best tools available. We are constantly working to keep pace with the speed of your innovation to provide you with the products you need.
New assays/kits for life science are available in innovative assay platforms such as AlphaLISA™ SureFire® Ultra™, AlphaLISA, HTRF™, and pHSense™, within several different therapeutic areas and research fields.
| Autoimmunity |
|---|
|
| Cardiovascular |
|---|
|
| Inflammation |
|---|
|
| Neuroscience |
|---|
|
| Oncology |
|---|
|
| Rare diseases |
|---|
|
| Virology |
|---|
|
| pHSense for ADCs and GPCRs |
|---|
|
NEW pHSense™ reagents for internalization studies
Discover a powerful new plate reader tool specifically designed for cell surface target internalization studies necessary for ADC and GPCR research.
pHSense probes are plate reader-compatible reagents with time-resolved fluorescence (TRF) readout specifically developed for internalization studies. This technology reinforces Revvity's commitment to advancing drug discovery workflows. pHSense offers:
- Higher throughput plate-based pH sensitive internalization reagents
- Superior signal-to-background for more reliable pharmacological data
- Versatility across suspension & adherent cells
Newest target videos
Discover brief animated videos providing information on specific targets and research areas that are addressed by our newly released assay kits!
Discover brief animated videos providing information on specific targets and research areas that are addressed by our newly released assay kits!
LRRK2 in Parkinson's disease
Key protein targets in TPD
Synthetic lethality in cancer
Aurora kinases in the cell cycle
The power of cytokines
Autophagy and its potential in therapeutics
HTT in Huntington’s disease pathology
AAVs as gene therapy vectors
Exploring Janus kinases
BRD proteins as therapeutic targets
LC3B: Key marker of autophagy
Targeting the ECM
How can we help you?
We are here to answer your questions.
